Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...

Researchers believe a simple blood test could flag people who are in the early stages of Alzheimer's, as well as spotting ...

D imaging and organoid models are revolutionizing dementia research, offering deeper insights into disease mechanisms and ...

TauRx Pharma's effort to bring a tau-targeting drug for ... four years in a new position paper. Eli Lilly has another approval for its anti-amyloid therapy for Alzheimer's disease, Kisunla ...

The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing how diseases develop and paving the way for simple blood tests to detect ...

The search for life-changing dementia treatments is beginning to yield tangible ... But there is hope. With over 140 drugs for Alzheimer’s disease currently in clinical trials and the recent positive ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

Aging involves gradual functional decline across various biological systems, including impaired cellular mechanisms such as ...

After the court declined in a 5-to-4 decision to block Donald J. Trump’s criminal sentencing, he is scheduled to face a New York judge on Friday morning. By Ben ProtessKate Christobek and Adam ...